Skip to content

Monday, September 26, 2022

Latest:

Reflections from a clinical ethics intern
National Postdoc Appreciation Week 2022
Healthy Habits: Dr. Ellen Friedman starts and ends the day with gratitude
From my Perspective: Dr. Debosmita Sardar shares her experiences during postdoctoral training
Collaboration, regional focus needed for dementia care in India

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

endocrine resistant breast cancer

From The Labs

Becoming metastatic: how FOXA1 triggers metastatic behavior in breast cancer

January 16, 2020January 16, 2020endocrine resistant breast cancer, ER positive breast cancer, FOXA1, HIF-2a, Metastatic breast cancer, Research

About 75 percent of breast cancers have estrogen receptors, hence they are called estrogen receptor positive (ER+). Original ER+ breast cancer cells depend on estrogen

From the Labs Video of the Month

From the Labs: RAIN-STORM 3D neuronal nanoscopic imaging